Show simple item record

EFFECT OF LOVASTATIN THERAPY AND WITHDRAWAL ON SERUM URIC ACID LEVEL IN TYPE II DIABETIC NEPHROPATHY

dc.contributor.authorNezami, N
dc.contributor.authorSafa, J
dc.contributor.authorArgani, H
dc.contributor.authorGhorbanihaghjo, A
dc.contributor.authorVatankhah, AM
dc.date.accessioned2018-08-26T08:11:30Z
dc.date.available2018-08-26T08:11:30Z
dc.date.issued2010
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/50677
dc.language.isoEnglish
dc.relation.ispartofATHEROSCLEROSIS SUPPLEMENTS
dc.relation.ispartof78th Congress of the European-Atherosclerosis-Society
dc.titleEFFECT OF LOVASTATIN THERAPY AND WITHDRAWAL ON SERUM URIC ACID LEVEL IN TYPE II DIABETIC NEPHROPATHY
dc.typeMeeting Abstract
dc.citation.volume11
dc.citation.issue2
dc.citation.spage209
dc.citation.epage209
dc.citation.indexWeb of science
dc.identifier.DOIhttps://doi.org/10.1016/S1567-5688(10)70994-6


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record